XML 23 R8.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Loss
Treasury Stock
Total DXC Equity
Non- Controlling Interest
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Total DXC Equity
Balance (in shares) at Mar. 31, 2019   270,214,000                  
Beginning balance at Mar. 31, 2019 $ 11,725 $ 3 $ 11,301 $ 478 $ (244) $ (136) $ 11,402 $ 323      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) (1,857)     (1,874)     (1,874) 17      
Other comprehensive income 77       68   68 9      
Share-based compensation expense 55   55       55        
Acquisition of treasury stock (15)         (15) (15)        
Share repurchase program (in shares)   (15,934,000)                  
Share repurchase program (736)   (669) (67)     (736)        
Stock option exercises and other common stock transactions (in shares)   1,326,000                  
Stock option exercises and other common stock transactions 14   14       14        
Dividends declared (165)     (165)     (165)        
Non-controlling interest distributions and other 3           0 3      
Balance (in shares) at Dec. 31, 2019   255,606,000                  
Ending balance at Dec. 31, 2019 9,101 $ 3 10,701 (1,628) (176) (151) 8,749 352      
Balance (in shares) at Mar. 31, 2019   270,214,000                  
Beginning balance at Mar. 31, 2019 $ 11,725 $ 3 11,301 478 (244) (136) 11,402 323      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                    
Balance (in shares) at Mar. 31, 2020   255,674,000                  
Ending balance at Mar. 31, 2020 $ 5,129 $ 3 10,714 (5,177) (603) (152) [1] 4,785 344 $ (4) $ (4) $ (4)
Balance (in shares) at Sep. 30, 2019   257,626,000                  
Beginning balance at Sep. 30, 2019 8,870 $ 3 10,793 (1,668) (428) (150) 8,550 320      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 90     82     82 8      
Other comprehensive income 283       252   252 31      
Share-based compensation expense 6   6       6        
Acquisition of treasury stock (1)         (1) (1)        
Share repurchase program (in shares)   (2,354,000)                  
Share repurchase program (86)   (98) 12     (86)        
Stock option exercises and other common stock transactions (in shares)   334,000                  
Dividends declared (54)     (54)     (54)        
Non-controlling interest distributions and other (7)           0 (7)      
Balance (in shares) at Dec. 31, 2019   255,606,000                  
Ending balance at Dec. 31, 2019 $ 9,101 $ 3 10,701 (1,628) (176) (151) 8,749 352      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Treasury shares (in shares) 2,148,708                    
Balance (in shares) at Mar. 31, 2020   255,674,000                  
Beginning balance at Mar. 31, 2020 $ 5,129 $ 3 10,714 (5,177) (603) (152) [1] 4,785 344 $ (4) $ (4) $ (4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 658     649     649 9      
Other comprehensive income 199       196   196 3      
Share-based compensation expense 33   33       33        
Acquisition of treasury stock (4)         (4) [1] (4)        
Stock option exercises and other common stock transactions (in shares)   1,127,000                  
Stock option exercises and other common stock transactions 1   1       1        
Non-controlling interest distributions and other (17)     (1)     (1) (16)      
Balance (in shares) at Dec. 31, 2020   256,801,000                  
Ending balance at Dec. 31, 2020 5,995 $ 3 10,748 (4,533) (407) (156) [1] 5,655 340      
Balance (in shares) at Sep. 30, 2020   256,522,000                  
Beginning balance at Sep. 30, 2020 4,751 $ 3 10,746 (5,631) (562) (155) [1] 4,401 350      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 1,103     1,098     1,098 5      
Other comprehensive income 156       155   155 1      
Share-based compensation expense 1   1       1        
Acquisition of treasury stock (1)         (1) [1] (1)        
Stock option exercises and other common stock transactions (in shares)   279,000                  
Stock option exercises and other common stock transactions 1   1       1        
Non-controlling interest distributions and other (16)           0 (16)      
Balance (in shares) at Dec. 31, 2020   256,801,000                  
Ending balance at Dec. 31, 2020 $ 5,995 $ 3 $ 10,748 $ (4,533) $ (407) $ (156) [1] $ 5,655 $ 340      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Treasury shares (in shares) 2,410,917                    
[1] 2,410,917 treasury shares as of December 31, 2020.